Literature DB >> 19333695

Comparison of surgical procedures for vitreous surgery in diabetic macular edema.

Tomoaki Shiba1,2, Yumi Kamura3, Fumihiko Yagi4, Yukihiro Sato4.   

Abstract

PURPOSE: Results of vitreous surgery alone in patients with diabetic macular edema (Vit group) were compared with results of surgery combined with peeling of the internal limiting membrane (ILM group), and surgery combined with removal of the residual vitreous cortex after its visualization using triamcinolone acetonide (TA) and a postoperative intravitreal TA injection (TA group). Visual acuities after the operation, degree of improvement in visual acuity (VA), and intra- and postoperative complications were evaluated.
METHODS: The study included 141 consecutive patients (168 eyes) who could be followed up for at least 12 months after the operation. The Vit group consisted of 66 eyes, the ILM group of 62 eyes, and the TA group of 40 eyes. Patient background factors, and visual acuities 6 and 12 months after operation were evaluated first, and at the final examination, the degree of improvement in VA, the incidences of intra- and postoperative complications, and the incidence of intraocular pressure > or =25 mmHg were studied.
RESULTS: Preoperative VA was compared with the 6- and 12-month postoperative VA and the VA at the final examination. The preoperative to 6 months postoperative improvements and those between the 12-month postoperative and final examination did not differ among the three groups. However, the degree of improvement in VA between 6 and 12 months after the operation was significantly smaller in the TA group than in the other two groups. The incidences of intra- and postoperative complications did not differ among the three groups, but the incidence of intraocular pressure >/=25 mmHg was slightly higher in the TA group.
CONCLUSION: Surgical results did not differ among the three operative techniques examined in this study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19333695     DOI: 10.1007/s10384-008-0639-2

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  24 in total

1.  Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.

Authors:  Teiko Yamamoto; Koichiro Hitani; Yukihiro Sato; Hidetoshi Yamashita; Shinobu Takeuchi
Journal:  Ophthalmologica       Date:  2005 Jul-Aug       Impact factor: 3.250

2.  Selective amplitude reduction of the PhNR after macular hole surgery: ganglion cell damage related to ICG-assisted ILM peeling and gas tamponade.

Authors:  Shinji Ueno; Mineo Kondo; Chang-Hua Piao; Kazuteru Ikenoya; Yozo Miyake; Hiroko Terasaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

3.  Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling.

Authors:  Nicholas E Engelbrecht; Jiong Freeman; Paul Sternberg; Thomas M Aaberg; Thomas M Aaberg; Daniel F Martin; Brian D Sippy
Journal:  Am J Ophthalmol       Date:  2002-01       Impact factor: 5.258

4.  Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

Authors:  Jost B Jonas; Robert F Degenring; Ingrid Kreissig; Imren Akkoyun; Bernd A Kamppeter
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

5.  Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Retina       Date:  2000       Impact factor: 4.256

6.  Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.

Authors:  J B Jonas; A Söfker
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

7.  Acute endophthalmitis following intravitreal triamcinolone acetonide injection.

Authors:  Darius M Moshfeghi; Peter K Kaiser; Ingrid U Scott; Jonathan E Sears; Matthew Benz; Juan P Sinesterra; Richard S Kaiser; Sophie J Bakri; Raj K Maturi; Jonathan Belmont; Paul M Beer; Timothy G Murray; Hugo Quiroz-Mercado; William F Mieler
Journal:  Am J Ophthalmol       Date:  2003-11       Impact factor: 5.258

8.  Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients.

Authors:  Yumi Kamura; Yukihiro Sato; Takako Isomae; Hiroyuki Shimada
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

9.  Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown.

Authors:  Taiji Sakamoto; Miho Miyazaki; Toshio Hisatomi; Takao Nakamura; Akifumi Ueno; Keiko Itaya; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-03-15       Impact factor: 3.117

10.  Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema.

Authors:  Yasutaka Mochizuki; Yasuaki Hata; Hiroshi Enaida; Keizo Yoshiyama; Miho Miyazaki; Akifumi Ueno; Toshinori Murata; Taiji Sakamoto; Toshiaki Kubota; Tatsuro Ishibashi
Journal:  Retina       Date:  2006-02       Impact factor: 4.256

View more
  4 in total

1.  Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema.

Authors:  Sachi Abe; Teiko Yamamoto; Yoshiko Kashiwagi; Eriko Kirii; Sakiko Goto; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2013-10-11       Impact factor: 2.447

2.  Efficacy and safety of vitrectomy with internal limiting membrane peeling for diabetic macular edema: a Meta-analysis.

Authors:  Xin-Ying Hu; Huan Liu; Li-Na Wang; Yu-Zhi Ding; Jie Luan
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

3.  Advances in the treatment of diabetic retinopathy.

Authors:  Ahmed M Abu El-Asrar; Hani S Al-Mezaine
Journal:  Saudi J Ophthalmol       Date:  2011-01-28

Review 4.  Evolving strategies in the management of diabetic retinopathy.

Authors:  Ahmed M Abu El-Asrar
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.